Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

The yin and yang of kidney development and Wilms' tumors.

Hohenstein P, Pritchard-Jones K, Charlton J.

Genes Dev. 2015 Mar 1;29(5):467-82. doi: 10.1101/gad.256396.114. Review.

2.

Wilms' tumour: connecting tumorigenesis and organ development in the kidney.

Rivera MN, Haber DA.

Nat Rev Cancer. 2005 Sep;5(9):699-712. Review. Erratum in: Nat Rev Cancer. 2005 Oct;5(10):835.

PMID:
16110318
3.

The roles of microRNAs in Wilms' tumors.

Yu X, Li Z, Chan MT, Wu WK.

Tumour Biol. 2016 Feb;37(2):1445-50. doi: 10.1007/s13277-015-4514-8. Epub 2015 Dec 3. Review.

PMID:
26634744
4.

Identical genetic changes in different histologic components of Wilms' tumors.

Zhuang Z, Merino MJ, Vortmeyer AO, Bryant B, Lash AE, Wang C, Deavers MT, Shelton WF, Kapur S, Chandra RS.

J Natl Cancer Inst. 1997 Aug 6;89(15):1148-52.

PMID:
9262253
5.
6.

Nephron Progenitor But Not Stromal Progenitor Cells Give Rise to Wilms Tumors in Mouse Models with β-Catenin Activation or Wt1 Ablation and Igf2 Upregulation.

Huang L, Mokkapati S, Hu Q, Ruteshouser EC, Hicks MJ, Huff V.

Neoplasia. 2016 Feb;18(2):71-81. doi: 10.1016/j.neo.2015.12.001.

7.

Expression of WT1 protein in fetal kidneys and Wilms tumors.

Grubb GR, Yun K, Williams BR, Eccles MR, Reeve AE.

Lab Invest. 1994 Oct;71(4):472-9.

PMID:
7967503
8.

A developmental context for multiple genetic alterations in Wilms' tumor.

Feinberg AP.

J Cell Sci Suppl. 1994;18:7-12. Review.

PMID:
7883796
9.

Expression of the PAX2 gene in human fetal kidney and Wilms' tumor.

Eccles MR, Wallis LJ, Fidler AE, Spurr NK, Goodfellow PJ, Reeve AE.

Cell Growth Differ. 1992 May;3(5):279-89.

10.

CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors.

Li CM, Kim CE, Margolin AA, Guo M, Zhu J, Mason JM, Hensle TW, Murty VV, Grundy PE, Fearon ER, D'Agati V, Licht JD, Tycko B.

Am J Pathol. 2004 Dec;165(6):1943-53.

11.

Role of the WT1 gene in Wilms' tumour.

Haber DA, Housman DE.

Cancer Surv. 1992;12:105-17. Review.

PMID:
1322241
12.

Wilms' tumour: reconciling genetics and biology.

Van Heyningen V, Hastie ND.

Trends Genet. 1992 Jan;8(1):16-21. Review.

PMID:
1369730
13.

[Wilms' tumors and malformation complexes].

Hata J, Fukuzawa R, Takata A, Kikuchi H.

Nihon Rinsho. 2000 Jul;58(7):1419-25. Review. Japanese.

PMID:
10921316
14.

Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.

Re GG, Hazen-Martin DJ, Sens DA, Garvin AJ.

Semin Diagn Pathol. 1994 May;11(2):126-35. Review.

PMID:
7809506
15.

Loss of heterozygosity at 2q37 in sporadic Wilms' tumor: putative role for miR-562.

Drake KM, Ruteshouser EC, Natrajan R, Harbor P, Wegert J, Gessler M, Pritchard-Jones K, Grundy P, Dome J, Huff V, Jones C, Aldred MA.

Clin Cancer Res. 2009 Oct 1;15(19):5985-92. doi: 10.1158/1078-0432.CCR-09-1065. Epub 2009 Sep 29.

16.

A CTCF-binding silencer regulates the imprinted genes AWT1 and WT1-AS and exhibits sequential epigenetic defects during Wilms' tumourigenesis.

Hancock AL, Brown KW, Moorwood K, Moon H, Holmgren C, Mardikar SH, Dallosso AR, Klenova E, Loukinov D, Ohlsson R, Lobanenkov VV, Malik K.

Hum Mol Genet. 2007 Feb 1;16(3):343-54. Epub 2007 Jan 8.

PMID:
17210670
17.

WT1: a novel tumor suppressor gene inactivated in Wilms' tumor.

Haber DA, Buckler AJ.

New Biol. 1992 Feb;4(2):97-106. Review.

PMID:
1313285
18.

The development of Wilms tumor: from WT1 and microRNA to animal models.

Tian F, Yourek G, Shi X, Yang Y.

Biochim Biophys Acta. 2014 Aug;1846(1):180-7. doi: 10.1016/j.bbcan.2014.07.003. Epub 2014 Jul 11. Review.

PMID:
25018051
19.

RNA expression of the WT1 gene in Wilms' tumors in relation to histology.

Miwa H, Tomlinson GE, Timmons CF, Huff V, Cohn SL, Strong LC, Saunders GF.

J Natl Cancer Inst. 1992 Feb 5;84(3):181-7.

PMID:
1311774
20.

Analysis of native WT1 protein from frozen human kidney and Wilms' tumors.

Iben S, Royer-Pokora B.

Oncogene. 1999 Apr 15;18(15):2533-6.

Supplemental Content

Support Center